Medscape Medical News, September 29, 2014 Alert EU Panel Likes 4 New Cancer Products The EMA's CHMP has recommended a new drug for non-small ... 3 studies show no new adverse effects and no ...
While this report establishes an important goal for the quality assessment and improvement of health care, it also poses a tremendous challenge. Preventable adverse drug events (pADEs), one of the ...
Channel 2 Action News has learned that the FDA is now alerting veterinarians about reports of health problems in dogs – ...
In a new report this week, the FDA highlighted several serious adverse events and deaths associated with the drug Librela.
The FDA has issued a “Dear Veterinarian” letter notifying practitioners about adverse events reported in dogs treated with ...
Daily Paws on MSN5d
FDA Warns Vets of Serious Complications Linked to Common Dog Arthritis Drug LibrelaLast week, the Food and Drug Administration (FDA) published a letter to veterinarians notifying them of severe adverse events ...
In response to a report of foreign material found in a sealed vial, Alcon Laboratories has initiated a voluntary recall of ...
The FDA's Center for Veterinary Medicine now is reporting a series of adverse events related to the drug. They include ataxia, seizures and other neurologic signs. Those include paresis, recumbency, ...
The agency recommended that the maker of Librela update its label to reflect the possibility of more serious adverse ...
The FDA is alerting veterinarians about reports of health problems in dogs, including hundreds of deaths, tied to a drug for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback